|
| 2-piperidin-1-yl-5-[[(E)-3-thiophen-2-ylprop-2-enoyl]amino]benzoic acid |
|
Staphylococcus |
Others |
Preclinical (in vitro) |
Chenna BC, et al. 2010. Eur J Med Chem |
|
| 3-hydroxy-2-phenyldiazenylbut-2-enoic acid |
|
Staphylococcus |
Others; Adherence; Biofilm |
Preclinical (in vitro) |
Maggio B, et al. 2016. Molecules |
|
| Phenazopyridine hydrochloride |
|
Staphylococcus |
TSST-1 (Toxic shock syndrome toxin-1) |
Preclinical (in vitro) |
Dufresne K, et al. 2024. J Biol Chem |
|
| 4-(5-bromo-1-butylindol-3-yl)pyrimidin-2-amine |
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
| 4-(5-bromo-1-ethylindol-3-yl)pyrimidin-2-amine |
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
| 4-(5-bromo-1-propylindol-3-yl)pyrimidin-2-amine |
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
| 4-(5-Bromo-1H-indol-3-yl)-N,N-dimethylpyrimidin-2-amine |
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
| 4-(5-bromo-1H-indol-3-yl)-N-ethylpyrimidin-2-amine |
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
| 4-(5-bromo-1H-indol-3-yl)-N-methylpyrimidin-2-amine |
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
| 4-(5-bromo-1H-indol-3-yl)pyrimidin-2-amine |
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
| | | |
